How to Check Corona Remedies IPO Allotment Status

Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The company was incorporated in August 2004.

As of June 30, 2025, the company's diverse portfolio includes 71 brands across therapeutic areas like women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals (including vitamins/minerals/nutrition, gastrointestinal, and respiratory). 

The Corona Remedies IPO came with a total issue size of ₹655.37 crore, comprising entirely an offer for sale of ₹655.37 crore. The IPO opened on December 8, 2025, and closed on December 10, 2025. The allotment is expected on Thursday, December 11, 2025. The share price band was set at ₹1008 to ₹1062 per share.

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Steps to Check Corona Remedies IPO Allotment Status on Registrar Site

• Visit the Bigshare Services Pvt. Ltd. 
• Select "Corona Remedies" from the dropdown menu on the allotment status page
• Enter your PAN ID, Demat Account Number, or Application Number in the designated field
• Complete the captcha verification process and click on the "Submit" button to view your allotment status

Steps to Check Corona Remedies IPO Allotment Status on BSE

• Navigate to the BSE IPO Allotment Status Page
• Select the issue type: equity/debt
• Choose "Corona Remedies" from the list of active IPOs in the dropdown menu
• Input your Application Number and PAN ID in the required fields
• Verify the captcha and click "Search" to check your allotment status

Corona Remedies IPO Subscription Status

Corona Remedies IPO received exceptional investor interest, being subscribed 144.50 times overall. Here is the category-wise breakdown as of 4:59:37 PM on December 10, 2025:

• QIB Category (Ex Anchor): 293.80 times
• Non-Institutional Investors (NII): 220.16 times
• Retail Investors: 30.33 times
• Employees: 15.53 times

Corona Remedies IPO Share Price and Investment Details

The minimum investment required was ₹14,868 for 1 lot (14 shares). The issue raised ₹194.86 crore from anchor investors and included 58,036 shares for employees at a discount of ₹54.00. Given the exceptional subscription of 144.50 times with very strong institutional, NII and retail participation, the share price is expected to list with a strong premium.

Utilisation of IPO Proceeds

As this IPO is entirely an offer for sale, the proceeds will go to the selling shareholders and not to the company.

Business Overview

Corona Remedies Limited is engaged in the manufacturing and marketing of pharmaceutical products across women’s healthcare, cardio-diabetes, pain management and other therapeutic segments. The company has a strong portfolio of specialized chronic medicines that offer higher margins. It reported steady growth in both revenue and profit during the stated periods and has paid dividends as well.

The company benefits from being the second fastest-growing among the top 30 Indian pharmaceutical companies by domestic sales from MAT June 2022 to MAT June 2025, building a diversified portfolio including several established brands, a pan-India sales network focused on the middle-income market segment, and strong manufacturing facilities with R&D capabilities that follow quality and Good Manufacturing Practices. It is supported by an experienced management team and marquee investors. Investors should note the post-issue P/E ratio of 35.15 and Price-to-Book Value of 10.71.